UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 20, 1995
Mycogen Corporation
-------------------
(Exact name of registrant as specified in its charter)
Delaware 0-15881 95-3802654
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5501 Oberlin Drive, San Diego, California 92121
(Address of principal executive offices)
Registrant's telephone number, including area code: 619-453-8030
Not Applicable
--------------
(Former name or former address, if changed since last report.)
ITEM 8. CHANGE IN FISCAL YEAR.
On April 20, 1995, the Board of Directors of Mycogen Corporation voted to
change the fiscal year end from December 31 to August 31. A Form 10-Q will be
filed for the quarter ending June 30, 1995 and a Form 10-K will be filed for the
eight-month transition period ending August 31, 1995.
Exhibit. Press release dated May 2, 1995.
- -------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Mycogen Corporation
-------------------
(Registrant)
Date: May 2, 1995 /s/ James A. Baumker
----------- --------------------
Controller, Chief Accounting Officer